-
Semaglutide TabletsProduct Name: Semaglutide tablets Indication Type 2 diabetes mellitus; Obesity Type Innovative Drug Form Injection Target Dual GLP/GIP receptor agonist Clinical progress Phase Ⅲread more
-
BGM0504 Injection GLP-1/GIP Receptor AgonistProduct Name: BGM0504 Injection GLP-1/GIP receptor agonist Indication Type 2 diabetes mellitus; Obesity Type Innovative Drug Form Injection Target Dual GLP/GIP receptor agonist Clinicalread more
-
Incretin Analogs BGM0504Product Name: Incretin Analogs BGM0504 Indication Type 2 diabetes mellitus; Obesity Type Innovative Drug Form Injection Target Dual GLP/GIP receptor agonist Clinical progress Phase Ⅲread more
-
Dual GLP-1/GIP Receptor Agonist BGM0504Product Name: Dual GLP-1/GIP receptor agonist BGM0504 Indication Type 2 diabetes mellitus; Obesity Type Innovative Drug Form Injection Target Dual GLP/GIP receptor agonist Clinicalread more
-
Semaglutide Oral Tablets 7mgProduct Name: Semaglutide Oral Tablet 7mg Indication Type 2 diabetes mellitus; Obesity Type Innovative Drug Form Injection Target Dual GLP/GIP receptor agonist Clinical progress Phase Ⅲread more
-
Semaglutide Weight Loss TabletsProduct Name: Semaglutide weight loss tablets Indication Type 2 diabetes mellitus; Obesity Type Innovative Drug Form Injection Target Dual GLP/GIP receptor agonist Clinical progressread more
-
Fondaparinux Sodium InjectionProduct Name: Fondaparinux Sodium Injection Cas. 114870-03-0 Molecular Formula C31H43N3Na10O49S8 Molecular Weight 1728.08 Appearance Colorless liquidread more
-
Micafungin Sodium InjectionProduct Name: Micafungin Sodium Injection Cas. 208538-73-2 Molecular Formula C56H72N9NaO23S Molecular Weight 1294.28 Appearance White or off-white solidread more
-
Oseltamivir Phosphate Suspension and CapsuleProduct Name: Oseltamivir Phosphate Suspension and Capsule Cas. 204255-11-8 Molecular Formula C16H31N2O8P Molecular Weight 410.4 Appearance White to off-white powder Storage Sealed,read more
-
Tiotropium Bromide and Olodaterol Hydrochloride SMIProduct Name: Tiotropium Bromide and Olodaterol Hydrochloride Appearance Colorless liquidread more
-
Minocycline Hydrochloride LAR InjectionProduct Name: Minocycline Hydrochloride LAR Injection Cas. 13614-98-7 Molecular Formula C23H28ClN3O7 Molecular Weight 493.94 Appearance Yellow crystalline powderread more
-
Leuprorelin Acetate LAR InjectionProduct Name: Leuprorelin Acetate LAR Injection Cas. 74381-53-6 Molecular Formula C61H88N16O14 Molecular Weight 1269.47 Appearance White to off-white powderread more
WEBFirst marketed by: Novo Nordisk. Name of FDF: Ozemopic®, Rybelsus®. Original FDF: RTU solution for subcutaneous injection. Other FDF: Oral tablets. Subcutaneous...
WEBSemaglutide (910463-68-2) reduces blood glucose through a mechanism where it stimulates insulin secretion and lowers glucagon secretion, both in a glucose-dependent...
WEBLatest U.S. Prescription Data for Drugs containing 910463-68-2 under Medicare's Part D Prescription Drug Program. Original Data: Centers for Medicare & Medicaid Services...
WEB1 day ago — CAS: 910463-68-2. Ref. 01-4091661. Estimated delivery in United States, on Wednesday 28 Aug 2024. Product Information. Name: Semaglutide. Synonyms:...
WEBAcylated GLP-1 analog with a half-life of 160 h. Semaglutide is under evaluation for the management of diabetes II. Due to its prolonged half-life, the peptide has to be injected...
WEBeMolecules Semaglutide | 910463-68-2 | | 250mg. Due to product restrictions, please Sign In to purchase or view availability for this product. The Fisher Scientific Encompass...
